N NBIX

Neurocrine Biosciences Inc

$180.79

-1.12% ($2.04)

Volume 1.07M

52W High $183.50

52W Low $122.14

Market Cap $17.95B

Next Earnings Report

No earnings data available for NBIX

Last 10 quarters

Q1 2026 May 6, 2026

1-Day: +1.75%

5-Day: +2.43%

Q1 2026 May 5, 2026

1-Day: +8.86%

Q1 2026 May 4, 2026

1-Day: +0.74%

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$805.5M	+28.3%	97.8%	26.2%	$153.7M
Q3'25	$794.9M	+27.8%	98.2%	30.1%	$209.5M
Q2'25	$687.5M	+16.5%	98.4%	21.2%	$107.5M
Q1'25	$572.6M	+11.1%	98.4%	4.1%	$7.9M
Q4'24	$627.7M	+21.8%	98.5%	22.6%	$103.1M
Q3'24	$622.1M	+24.7%	98.7%	29.6%	$129.8M
Q2'24	$590.2M	+30.4%	98.4%	24.6%	$65.0M
Q1'24	$515.3M	+22.6%	98.5%	19.3%	$43.4M

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q2 2026	Jul 29, 2026	$2.19	$2.39	--	--	--
Q1 2026	May 6, 2026	$1.11	$1.14	$1.94	+74.77%	Beat
Q1 2026	May 5, 2026	$1.70	$1.69	$1.94	+14.12%	Beat
Q1 2026	May 4, 2026	$1.73	$1.73	--	--	--
Q4 2025	Feb 11, 2026	$2.30	$2.23	$1.88	-18.26%	Missed
Q3 2025	Oct 30, 2025	$2.09	$1.99	$2.17	+3.83%	Beat
Q3 2025	Oct 28, 2025	$2.07	$2.02	$2.17	+4.83%	Beat
Q2 2025	Jul 30, 2025	$1.50	$1.33	$1.65	+10.00%	Beat
Q1 2025	May 5, 2025	$1.09	$0.95	$0.70	-35.78%	Missed
Q4 2024	Feb 6, 2025	$1.93	$1.79	$1.69	-12.44%	Missed
Q3 2024	Oct 30, 2024	$1.82	$1.65	$1.81	-0.55%	Beat
Q2 2024	Aug 1, 2024	$1.53	$1.03	$1.63	+6.54%	Beat